Industry News
Pharmaceutical Industry News
China’s Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses
China's Sinovac, Sinopharm ink COVAX supply deal for up to 550M coronavirus vaccine doses nhigginsdunn Mon, 07/12/2021 - 11:21
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst aliu Mon, 07/12/2021 - 10:29
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs
With sweeping executive order, Biden puts drug pricing, anti-competitive strategies in the crosshairs fkansteiner Mon, 07/12/2021 - 09:51
Pfizer to meet with FDA to discuss COVID-19 boosters, but will the U.S. get on board?
Pfizer to meet with FDA to discuss COVID-19 boosters, but will the U.S. get on board? kdunleavy Mon, 07/12/2021 - 09:36
BioBonds Use Wall Street Tools to Fund Medical Research
Karen Petrou invented a new funding model for curing blindness. Proposed legislation aims to apply it to medical research more generally.
Horizon teams up with Olympic champion to raise awareness around Graves’ disease and thyroid eye disease
Horizon teams up with Olympic champion to raise awareness around Graves' disease and thyroid eye disease sharon.coey Mon, 07/12/2021 - 03:37
Sunovion takes Urovant’s overactive bladder med Gemtesa to primary care docs as promo partnership launches
Sunovion takes Urovant's overactive bladder med Gemtesa to primary care docs as promo partnership launches bbulik Sun, 07/11/2021 - 20:57
Biden Urges More Scrutiny of Big Businesses, Such as Tech Giants
An executive order reflects the administration’s growing embrace of warnings by some economists that declining competition is hobbling the economy’s vitality.
What Is Critical Race Theory?
And how to learn more about the issue dividing school districts across the country.
Seagen, Astellas’ Padcev snares full approval and expands into second-line treatment on path to blockbuster land
Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land fkansteiner Fri, 07/09/2021 - 16:34
Seagen, Astellas’ Padcev snares full approval and expands into second-line treatment on path to blockbuster land
Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land fkansteiner Fri, 07/09/2021 - 16:34
Seagen, Astellas’ Padcev snares full approval and expands into 2nd-line treatment on path to blockbuster land
Seagen, Astellas' Padcev snares full approval and expands into 2nd-line treatment on path to blockbuster land fkansteiner Fri, 07/09/2021 - 16:34
F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval
The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
Bayer’s Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients nhigginsdunn Fri, 07/09/2021 - 15:32
Bayer’s Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients nhigginsdunn Fri, 07/09/2021 - 15:32
¿Te preocupa la variante Delta? Las investigaciones muestran que las vacunas son eficaces contra ella
Israel informó que la vacuna de Pfizer tenía una efectividad del 64 por ciento contra la variante Delta. Otras investigaciones sugieren una tasa más alta.
A New Alzheimer’s Drug Offers More Questions Than Answers
The approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted.
In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. Now it recommends that the drug be given only to those with mild symptoms.
FDA chief asks for independent investigation into approval of Biogen’s Alzheimer’s drug Aduhelm
FDA chief asks for independent investigation into approval of Biogen's Alzheimer's drug Aduhelm nhigginsdunn Fri, 07/09/2021 - 13:46
After 5-month hiatus, bluebird bio’s Zynteglo bounces back in Europe with all-clear from safety group
After 5-month hiatus, bluebird bio's Zynteglo bounces back in Europe with all-clear from safety group nhigginsdunn Fri, 07/09/2021 - 11:21